Will Zoetis' Acquisition Spree Pay Off?
There is more than one way to grow a business, and animal healthcare company Zoetis (NYSE: ZTS) has shown that making acquisitions can be a viable option. Over the past few years, Zoetis has expanded by buying businesses in tangential areas to its core animal pharmaceutical business. Will this buying spree pay off?
Zoetis has made no less than eight acquisitions over the past few years, half of which are related to its push into the veterinary diagnostics space. Animal health diagnostics is one of the fastest-growing parts of the veterinary industry, with a high-single-digit growth rate expected in the coming years.
Data source: Company financial reports and press releases.
Source Fool.com
